New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment);Nová evidence-based kritéria pro posouzení vhodnosti lékového režimu u seniorů. Kritéria STOPP (Screening Tool of Older Person's Prescriptions) a START (Screening Tool to Alert doctors to Right Treatment)

Vnitrni Lekarstvi

Volumn 54, Issue 12, 2008, Pages 1161-1169

  Topinková, Eva ^a,b   Madlova P ^a,b   Fialova D ^a,c   Klan J ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b IPVZ   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Appropriate drugs in old age; Elderly; Evidence based pharmacotherapy; STOPP and START criteria

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORDIAZEPOXIDE; CHLORPHENIRAMINE; CHLORPROMAZINE; CLOPIDOGREL; CLORAZEPATE; CYCLIZINE; DIGOXIN; DILTIAZEM; DIPHENHYDRAMINE; DIPYRIDAMOLE; DIURETIC AGENT; FLURAZEPAM; GLIBENCLAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IPRATROPIUM BROMIDE; LEVOMEPROMAZINE; LOPERAMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRAZEPAM; OPIATE ANTAGONIST; PROCHLORPERAZINE; PROMETHAZINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ADVERSE OUTCOME; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CZECH REPUBLIC; DIGESTIVE SYSTEM; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INTERACTION; DRUG SAFETY; DRUG SCREENING; ENDOCRINE SYSTEM; EUROPE; EVIDENCE BASED PRACTICE; GASTROINTESTINAL TRACT; GERIATRIC ASSESSMENT; GERIATRIC CARE; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; MORBIDITY; MUSCULOSKELETAL SYSTEM; PHYSICIAN; PRESCRIPTION; QUALITY CONTROL; REVIEW; STANDARDIZATION; UROGENITAL SYSTEM;

AGED; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 57749193333     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Juurlink DN, Mamdami M, Kopp A et al. Drug-drug interactions among elderly patients hospitalised for drug toxicity. JAMA 2003; 289: 1652-1658.
2. Goldberg RM, Mabee J, Chan L et al. Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-450.
3. Kriška M, Wawruch M. Dilema farmakoterapie ν geriatrii. Problém polypragmazie a interakcií. Geriatria 2002; 8: 132-137.
4. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 6-14.
5. Fialová D, Topinková E. Specifické rysy geriatrické farmakoterapie z pohledu farmakokinetických a farmakodynamických změn ve stáří. Remedia 2002; 12: 434-440.
6. Tinetti M. Preventing falls in elderly persons. New Engl J Med 2003; 348: 42-49.
7. Hanlon JT, Horner RD, Schmader KE et al. Benzodiazepine use and cognitive function among community dwelling elderly. Clin Pharmacol Ther 1998; 64: 684-692.
8. Gray SL, LaCroix AZ, Hanlon JT et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54: 224-230.
9. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs; a meta-analysis. Ann Intern Med 1991; 115: 787-796.
10. Garcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications. Systematic review of epidemiological studies. Br J Clin Pharmacol 2001; 52: 563-571.
11. Sommer B, Fenn H, Pompei P et al. Safety of antidepressants in the elderly. Expert Opin Drug Saf 2003; 2: 367-383.
12. Onder G, Pedone C, Landi F et al. Adverse drug reactions as a cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-1968.
13. Topinková E, Fialová D. Geriatrická farmakoterapie - léčiva nevhodná pro starší nemocné. Postgrad Med 2006; 8 (mimořádná příloha): 28-35.
14. Topinková E. Máme dostatek vědeckých důkazů pro farmakoterapii seniorů. Ageismus v klinických studiích. Postgrad Med 2008; 10: 571-585.
15. Spinewine A, Schmader KE, Barber N et al. Appropriate prescribing in elderly people: how well can it be measured and optimized? Lancet 2007; 370: 173-184.
16. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-346.
17. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population based study of the very old. Drugs Aging 2005; 22: 69-82.
18. Spinewine A, Swine C, Dhillon S et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomised, controlled trial. J Am Geriatr Soc 2007; 55: 658-665.
19. Beers MH, Ouslander JG, Rollingher I et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832.
20. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-1536.
21. Fick DM, Cooper JW, Wade W et al. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults - Results of a US Consensus Panel of Experts. Arch Intern Med 2003; 163: 2716-2724.
22. Naugler CT, Brymer C, Stolee P et al. Development and Validation of an Improved Prescribing for the Elderly Tool. Can J Clin Pharmacol 2000; 7: 103-107.
23. Hanlon JT, Schmader KE, Sansa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051.
24. Fialová D, Topinková E. Koncept léčiv nevhodných ve stáří - farmakologické a farmakoepidemiologické aspekty. Remedia 2005; 15: 410-417.
25. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-346.
26. Fialova D, Topinkova E, Gambassi G et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-1358.
27. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling elderly patients: a population based survey. Arch Intern Med 2002; 162: 1707-1712.
28. van der Hooft CS, Jong GW, Dieleman JP et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population based cohort study. Br J Clin Pharmacol 2005; 60: 2137-2144.
29. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725-731.
30. Vinšová J, Fialová D, Topinková E et al. Prevalence a vývojové trendy v preskripci léčiv potencialně nevhodných ve stáří v České republice. Prakt Lék 2006; 86: 722-728.
31. Wawruch M, Fialová S, Žikavská M et al. Používanie potencialne nevhodných liečiv pre starších pacientov v regione bývalého Česko-Slovenska. Klin Farmakol Farm 2008; 22: 108-112.
32. Rochon PA, GurwitzJH. Prescribing for seniors: neither too much nor too little. JAMA 1999; 282: 113-115.
33. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 138-141.
34. Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated? Arch Intern Med 2004; 164: 1701.
35. Gallagher PF, Barry PJ, Ryan C et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 2008; 37: 96-101.
36. Oborne CA, Hooper R, Swift GG et al. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003; 32: 102-108.
37. Batty GM, Grant RL, Aggarwal R et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing 2003; 32: 292-298.
38. Shekelle PG, Maclean CH, Morton SC. ACOVE quality indicators. Ann Intern Med 2001;135:653-667.
39. Gallagher P, Ryan C, Byrne S et al. STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): Consensus Validation. Int J Clin Pharm Ther: 2008; 46: 72-83.
40. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
41. Topinková E et al. Nepublikované výsledky, 2008.
42. Gallagher P, O'Mahony D STOPP (Screening Tool of Older People's potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing, in press.
43. Barry P, Gallagher P, Ryan C et al. START Screening Tool to Alert Doctors to Right Treatment. An evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 628-631.
44. Krska J, Cromarty JA, Arris F et al. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 2001; 30: 205-211.